Evidence map›Paper›PMID 15210585›Full record

ArticleBritish journal of pharmacology2004

Peripheral GABAB agonists stimulate gastric acid secretion in mice.

Laura Piqueras, Vicente Martinez

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. GABAMedComm · 2025
    Review
  2. Article
  3. Article
  4. eLife · 2022
    Article
  5. Article
  6. Embryonic Thermal Manipulation andFrontiers in veterinary science · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Laura PiquerasDepartment of Physiology, Pharmacology and Toxicology, Cardenal Herrera CEU University, Valencia, Spain.
Vicente Martinez
Universidad Cardenal Herrera CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1 We characterized the effects of intravenous GABA and preferential GABAA (muscimol), GABAB (R-baclofen and SKF-97541) and GABAC agonists (imidazole-4-acetic acid) on gastric acid secretion in urethane-anesthetized mice implanted with a gastric cannula, and determined the role of vagal cholinergic mechanisms, and gastrin and somatostatin by using peptide immunoneutralization, the SSTR2 antagonist, PRL-2903, and SSTR2 knockout mice. 2 The selective GABA(B) agonists R-baclofen (0.1-3 mg kg(-1), i.v.) and SKF-97541 (0.01-0.3 mg kg(-1), i.v.) induced a dose-related stimulation of gastric acid secretion. SKF-97541 was about 10 times more potent than R-baclofen stimulating gastric acid secretion. Neither GABA (0.1-100 mg kg(-1), i.v.) nor muscimol (0.1-3 mg kg(-1)) nor imidazole-4-acetic acid (0.1-10 mg kg(-1)) affected basal gastric acid secretion. 3 Stimulatory effects of SKF-97541 (0.1 mg kg(-1), i.v.) were blocked by the selective GABAB antagonist, 2-hydroxysaclofen, cholinergic blockade with atropine, subdiaphragmatic vagotomy or gastrin immunoneutralization. 4 Somatostatin immunoneutralization or SSTR2 blockade with PRL-2903 enhanced the secretory response to SKF-97541 (0.1 mg kg(-1), i.v.) by 78 and 105%, respectively. 5 In SSTR2 knockout mice, SKF-97541 (0.1 mg kg(-1), i.v.) increased basal gastric acid secretion by 48%. Neither GABA nor muscimol nor imidazole-4-acetic acid modified basal gastric acid secretion in SSTR2 knockout mice. 6 These results indicate that, in mice, stimulation of GABAB receptors increases gastric acid secretion through vagal- and gastrin-dependent mechanisms. Somatostatin implication might be secondary to the release of gastrin and the increase in gastric luminal acidity.

Indexed as

GABA-B Receptor AgonistsAnimalsAntibodies, MonoclonalAtropineBaclofenDeoxyglucoseDose-Response Relationship, DrugGABA AgonistsGABA AntagonistsGABA-A Receptor Agonistsgamma-Aminobutyric AcidGastric AcidGastrinsImidazolesInjections, IntravenousMale2-hydroxysaclofen3-aminopropyl(methyl)phosphinic acidAntibodies, MonoclonalAtropineBaclofenDeoxyglucoseGABA AgonistsGABA AntagonistsGABA-A Receptor AgonistsGABA-B Receptor AgonistsGABA-C receptorgamma-Aminobutyric AcidGastrinsimidazoleacetic acidImidazolesMuscimolOrganophosphorus CompoundsPentagastrinPeptides, CyclicPRL 2903Receptors, GABAReceptors, GABA-AReceptors, GABA-BReceptors, SomatostatinSomatostatinSstr2 protein, mouse

Identifiers

PMID15210585
PMCPMC1575121
OpenAlexW2046717932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.